Introduction State of the Art Dengue Vaccine Development Challenges in Dengue Vaccine Development Emerging Opportunities for Advancing Dengue Vaccine References State of the Art Dengue Vaccine ...
Under pressure to rebuild as sales of its blockbuster Lantus slide, Sanofi desperately needed the launch of its Dengue vaccine to run smoothly. But it hasn’t. Analysts had expected blockbuster ...
News Medical on MSN1d
The growing list of human viruses: Are we prepared for the next outbreak?Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...
The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue ...
News Medical on MSN2d
PAHO issues alert on rising risk of dengue outbreaks in the AmericasThe Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue outbreaks in the Americas, attributed to the growing circulation of the DENV-3 ...
A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...
The Pan American Health Organization (PAHO) is warning that a dengue strain, the DENV-3 serotype, is on the rise in the Caribbean which could lead to a potential increase in cases of the disease. It ...
Researchers have unveiled new insights into how weather influences the spread of dengue fever. Their study identifies ...
Dr. Lulu Bravo, a prominent vaccinologist and vaccine advocate, has been vocal in dispelling common misconceptions surrounding the dengue vaccine. With decades of experience in vaccine development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback